Vivani to Spin Off Neurostimulation Business as Cortigent

Vivani Medical announced plans to spin off its neurostimulation division into an independent, publicly traded company, Cortigent, which is expected to launch in Q3 2025. Cortigent will advance brain implants that restore vision and movement, including the Orion Cortical Visual Prosthesis System for blindness and a neurostimulation device for stroke recovery.

Vivani acquired the technology through a 2022 merger with Second Sight but shifted its focus to GLP-1 implants. The spinoff aims to give shareholders direct participation in Cortigent’s future as it seeks regulatory approvals and funding.